39968-95-1

Basic information

• Product Name: 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]corey lactone
• Synonyms: 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]corey lactone;(3aR,4S,5R,6aS)-5-((tert-butyldimethylsilyl)oxy)-4-(hydroxymethyl)hexahydro-2H-cyclopenta[b]furan-2-one
• CAS NO: 39968-95-1
• Molecular Formula: C₁₄H₂₆O₄Si
• Molecular Weight: 286.43934
• Mol File: 39968-95-1.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Density: 1.07
• CAS DataBase Reference: 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]corey lactone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]corey lactone(39968-95-1)
• EPA Substance Registry System: 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]corey lactone(39968-95-1)

Safety Data

• Hazardous Substances Data: 39968-95-1(Hazardous Substances Data)

Usage

General Description

2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]corey lactone is a chemical compound that belongs to the class of lactones, which are cyclic esters of hydroxy acids. This specific compound contains a corey lactone ring with a tert-butyldimethylsilyl (TBDMS) group attached to the oxygen atom. The TBDMS group is often used in organic synthesis to protect hydroxyl groups and prevent unwanted reactions, making this compound useful in the creation of various organic compounds. Additionally, the presence of the dimethylsilyl group can make the molecule more stable and less reactive. Overall, 2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]corey lactone is a versatile compound with potential applications in organic synthesis and chemical research.

Upstream product

• 32233-40-2 (3aR,4S,5R,6aS)-5-hydroxy-4-(hydroxymethyl)hexahydro-2H-cyclopenta[b]furan-2-one 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 117624-93-8 (1S,5R,6R,7R)-6-<<(tert-butyldimethylsilyl)oxy>methyl>-7-<(tert-butyldimethylsilyl)oxy>-2-oxabicyclo<3.3.0>octane-3-one 
• 62939-85-9 (-)-7α-hydroxy-6β-triphenylmethoxymethyl-cis-2-oxabicyclo<3.3.0>octan-3-one 
• 39746-00-4 (1S,5R,6S,7R)-7-benzoyloxy-6-hydroxymethyl-2-oxabicyclo[3.3.0]octan-3-one 
• 101208-17-7 (3aR,4S,5R,6aS)-5-(benzoyloxy)hexahydro-4-[(triphenylmethoxy)methyl]-2H-cyclopenta[b]furan-2-one 
• 912445-64-8 (3aR,4S,5R,6aS)-5-(tert-butyldimethylsilyloxy)-4-(trityloxymethyl)-hexahydrocyclopenta(b)furan-2-one 
• 64091-14-1 (3aR,4R,5R,6aS)-5-((tert-butyldimethylsilyl)oxy)-2-oxohexahydro-2H-cyclopenta[b]furan-4-carbaldehyde 
• 57930-46-8 (1S,5R,6R,7R)-(-)-6-acetoxymethyl-7-hydroxy-2-oxabicyclo<3.3.0>octan-3-one 

Downstream Products

• 26198-80-1 (Z)-9-((1R,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)non-7-enoic acid 
• 57944-39-5 (Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)cyclopentyl)non-7-enoic acid 
• 551-11-1 dinoprost 

Relevant articles and documents

Synthetic method of bimatoprost

The invention relates to a synthetic method of bimatoprost, and belongs to the technical field of chemical synthesis. According to the method, doxazosin is synthesized by adopting the following synthesis route different from the conventional technology, s

Stereoselective preparation of key intermediates for the synthesis of iso-, neuro- and phyto-prostane family members: Inaugural asymmetric synthesis of 17-E2c-dihomo- and 17-F2c-dihomo-isoprostanes

A practical methodology for the synthesis of key intermediates for isoprostane, neuroprostane and dihomo-isoprostane preparation has been described. The key strategy involved a three stage C-12 stereocenter inversion of the configuration of a Corey lacton

Stereospecific Synthesis of Fluoroalkenes by Silver-Mediated Fluorination of Functionalized Alkenylstannanes

The known procedures for the conversion of alkenylstannanes into the corresponding fluoroalkenes suffer from largely variable yields and a limited compatibility with functional groups; most notably, protodestannation becomes a serious issue whenever protic sites are present in the substrate. Outlined in this paper is a convenient alternative with a much improved application profile, which is largely unperturbed by free alcohols and amides of all sorts. Key to success is the use of F-TEDA-PF6in combination with non-hygroscopic and bench-stable silver phosphinate (AgOP(O)Ph2) that acts as an essentially neutral, non-nucleophilic promotor and effective tin-scavenger at the same time. This new method opens many opportunities for late-stage fluorination of elaborate compounds far beyond the scope of the literature procedures, as witnessed by the preparation of a fluorinated macrolide antibiotic, a fluorinated prostaglandin derivative, and a set of fluorinated amino acid surrogates and peptide isosteres.